Market Tracker

03/27 7:45pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

11.78
Delayed Data
As of Mar 27
 +0.46 / +4.06%
Today’s Change
7.09
Today|||52-Week Range
12.11
+41.93%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close11.32
Today’s open11.37
Day’s range11.32 - 11.85
Volume972,473
Average volume (3 months)502,347
Market cap$519.4M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+150.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio30.0
Price/Sales2.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PRQRProQR Therapeutics N...+0.14+0.60%
LBIOLion Biotechnologies...-0.39-3.36%
SRPTSarepta Therapeutics...+0.50+3.83%
VSARVersartis Inc-0.64-3.21%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts